Verastem | VSTM - Gross Profit On Sales


Verastem reported $15.62M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
AstraZeneca USD 12.86B 251M Jun/2026
Curis USD 1.14M 8.86M Dec/2025
Cytokinetics USD 19.2M 1.44M Mar/2026
Gilead Sciences USD 5.52B 791M Mar/2026
Incyte USD 1.57B 400.89M Jun/2026
Laboratory Of America USD 1.11B 98.2M Jun/2026
Novartis USD 11.24B 1.18B Jun/2026
Pfizer USD -248M 11.29B Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
TG Therapeutics USD 199.14M 27.73M Jun/2026
Verastem USD 15.62M 977K Mar/2026